How were Covance's earnings last quarter?

Covance Inc (NYSE:CVD) announced its quarterly earnings results on Wednesday, February, 4th. The healthcare company reported $0.97 earnings per share for the quarter, meeting the consensus estimate of $0.97. The healthcare company had revenue of $634 million for the quarter, compared to analysts' expectations of $631.30 million.

What other stocks do shareholders of Covance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Covance investors own include Allena Pharmaceuticals (ALNA) , Laboratory Co. of America (LH) , Arbutus Biopharma (ABUS) , Ampliphi Biosciences (APHB) , Asterias Biotherapeutics (AST) , Catalyst Biosciences (CBIO) , Crestwood Equity Partners (CEQP) , Cisco Systems (CSCO) , Fate Therapeutics (FATE) and Flexion Therapeutics (FLXN) .

NYSE:CVD

Covance (CVD) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free CVD Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Covance alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Covance Stock (NYSE:CVD)

Covance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

CVD Stock News Headlines

February 23, 2024 | msn.com

New study shows glycan sugar coating of IgG immunoglobulin can predict cardiovascular health

January 26, 2024 | msn.com

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

October 8, 2023 | msn.com

“Unblocked” movement to tackle burden of cardiovascular diseases

October 6, 2023 | reuters.com

Antidumping separate rate process and pitfalls importers should consider

September 24, 2023 | investing.com

CVD Historical Data

August 26, 2023 | msn.com

Feeling safe from crime ‘reduces heart attack risk’

July 27, 2023 | finance.yahoo.com

CVV - CVD Equipment Corporation

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

May 22, 2023 | benzinga.com

Holter ECG Market is Expected to Reach $558 million | MarketsandMarkets.

May 8, 2023 | technews.tmcnet.com

UCARDIA ANNOUNCES ACQUISITION OF PHAS3; LAUNCHES CARDIOLOGIST PRACTICE REMOTE PATIENT MONITORING OFFERING

July 21, 2022 | marketwatch.com

Analgesics Market 2022 Size, Demand, Outlook, Trends, Revenue, Future Growth Opportunities till 2030

May 10, 2022 | finance.yahoo.com

People Who Have Had COVID-19 More Likely to Develop Cardiovascular Disease: New Report Highlights the Need to Refocus on Cardiovascular Care

May 4, 2022 | thestreet.com

Cramer's 'Mad Money' Recap: Stake Out AeroVironment

March 14, 2022 | msn.com

People with serious mental illness more likely to have heart disease – study

March 13, 2022 | msn.com

People with serious mental illness more likely to suffer from heart disease – study

January 31, 2022 | ca.finance.yahoo.com

1 Top Healthcare Stock to Buy Low Today

January 21, 2022 | thestreet.com

Covance Stock Hits New 52-Week High (CVD)

October 26, 2021 | finance.yahoo.com

Novartis launches Not Another Minute to educate Canadians and take action to bend the curve of cardiovascular disease (CVD)

September 28, 2021 | msn.com

World Heart Day 2021: Know all about the date, history, significance and theme

See More Headlines

Receive CVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covance and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/04/2015
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: N/A
Industry: N/A
Sub-Industry: Life Sciences Tools & Services
Current Symbol: NYSE:CVD
CUSIP: 22281610
CIK: 1023131
Web: www.covance.com
Phone: +1-609-4524440
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

CVD Stock Analysis - Frequently Asked Questions

How were Covance's earnings last quarter?: Covance Inc (NYSE:CVD) announced its quarterly earnings results on Wednesday, February, 4th. The healthcare company reported $0.97 earnings per share for the quarter, meeting the consensus estimate of $0.97. The healthcare company had revenue of $634 million for the quarter, compared to analysts' expectations of $631.30 million.
What other stocks do shareholders of Covance own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Covance investors own include Allena Pharmaceuticals (ALNA), Laboratory Co. of America (LH), Arbutus Biopharma (ABUS), Ampliphi Biosciences (APHB), Asterias Biotherapeutics (AST), Catalyst Biosciences (CBIO), Crestwood Equity Partners (CEQP), Cisco Systems (CSCO), Fate Therapeutics (FATE) and Flexion Therapeutics (FLXN).

This page (NYSE:CVD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Covance (CVD) Stock Price, News & Analysis

About Covance Stock (NYSE:CVD)

CVD Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

CVD Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info